Skip to main content

Table 3 Correlation analysis with glucocorticoid dose and duration

From: Glucocorticoid use in psoriatic arthritis and treatment outcomes: does the gender have a role?

Variable

Dose

Duration

Age

0.057

0.197

Gender

0.054

0.159

Duration

0.292

0.298

DIP involvement

0.139

0.327

Large joint involvement

0.962

0.962

Enthesitis

0.065

0.480

Dactylitis

0.034*

0.630

Axial involvement

0.503

0.609

Nail psoriasis

0.628

0.628

Pustular psoriasis

0.645

0.645

TJS

0.264

0.000*

SJS

0.300

0.027*

CRP

0.003*

0.006*

DAS 28

0.031*

0.000*

DAPSA

0.021*

0.000*

GC dose

NA

0.000*

GC duration

0.000*

NA

  1. DIP distal interphalangeal joint, TJS tender joint count, SJS swollen joint count, CRP C reactive protein, DAS-28 disease activity score-28, DAPSA Disease Activity Index for Psoriatic Arthritis, GC glucocorticoid
  2. *Significance (P ≤ 0.05 is statistically significant)